Stay updated on Isatuximab Combo in High-Risk Myeloma Clinical Trial
Sign up to get notified when there's something new on the Isatuximab Combo in High-Risk Myeloma Clinical Trial page.

Latest updates to the Isatuximab Combo in High-Risk Myeloma Clinical Trial page
- Check4 days agoChange DetectedThe record history shows the revision label updated from v3.6.0 to v3.6.2, reflecting a small update to the page's versioning information.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe study record history shows a new Revision: v3.6.0 entry with associated UI labels such as 'Check who can join', 'Find Contact Information', and 'Study Status', and an older Revision: v3.5.5 tag was removed, indicating an update to the versioning metadata.SummaryDifference2%

- Check25 days agoChange DetectedThe revision label in the page footer was updated from v3.5.4 to v3.5.5, reflecting a newer published version of the page.SummaryDifference0.1%

- Check39 days agoChange DetectedA new Study Status entry and a new version timestamp were added in May 2026, and an older history entry from November 2025 was removed, reflecting an update to how the record's status and revisions are tracked.SummaryDifference0.4%

- Check47 days agoChange DetectedThe page history now shows a new revision (v3.5.4) replacing the previous revision (v3.5.3), indicating a formal update to the study record history.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page’s footer revision label was updated from v3.5.2 to v3.5.3, indicating a website/version update without changing the study record details shown.SummaryDifference0.1%

Stay in the know with updates to Isatuximab Combo in High-Risk Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Isatuximab Combo in High-Risk Myeloma Clinical Trial page.